Skip to content

Category: News

Katie Couric, Mark McClellan, and Ellen Sigal Huffington Post Op-Ed on 21st Century Cures

Congress Must Pass 21st Century Cures Act Now This is an incredibly exciting time in biomedical research. New discoveries are announced almost every week that bring us closer to managing cancer and other life-threatening diseases. We are attacking these illnesses at the molecular and genetic levels. In cancer, for example, scientists have gone beyond treating…

In Case You Missed It: Highlights from March, April, May & June 2015

It’s been a busy spring for drug development. We’ve had leadership changes at FDA, legislative pushes in Congress, and a host of conferences and meetings to present and advance ideas from the cutting edge of science and policy. It’s a lot of keep up with. Here are the biggest stories from the last few months.…

21st Century Cures is Moving Quickly Through the Legislative Process – Here’s What You Should Know

This Friday, the U.S. House will vote on the 21st Century Cures Act. The Act creates a cohesive, efficient, effective, and patient-centered path to cures. The 21st Century Cures Act, a substantial piece of legislation that touches on all aspects of medical innovation – from basic research to regulation, from biomarkers to patient data –…

A Conversation with NIH Director Dr. Francis Collins

  Welcome to Engaging Innovation! This multi-media forum will be a venue for leaders from the public and private sector, regulators, drug developers, researchers, providers, patients, and advocates to engage on important issues and discuss the most pressing challenges and the most compelling innovations in the fight against cancer. We are thrilled to have Dr.…